Skip to main content

dasiglucagon

Generic: DASIGLUCAGON HYDROCHLORIDE·Brand: ZEGALOGUE, ZEGALOGUE (AUTOINJECTOR), Zegalogue

dasiglucagon: 2 clinical trials tracked.

dasiglucagon evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about dasiglucagon, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Diabetes Mellitus, Type 1
Clinical Trials (2)

A Phase 3, Randomised, Open-label, Cross-over Study to Confirm the Clinical Efficacy and Safety of Dasiglucagon Versus Glucagon for the Treatment of Severe Hypoglycaemia in Asian Adults With Type 1 Diabetes (T1D) Including an Investigation of Dasiglucagon in a Japanese Adolescent Cohort

NCT06588504·Phase 1·NVO
Completed

Primary endpoint: Adults cohort: Time to plasma glucose (PG) recovery, where PG recovery is defined as the first increase in PG of greater than or equal to (>=) 20 milligrams per decilitre (mg/dL) (1.1 millimoles per litre [mmol/L]) from baseline

InterventionalRandomizedopen38 enrolledStarted 2024-09Completion 2025-071 site · JapanNovo Nordisk A/S

Phase 3, Single-administration, Open-label Trial to Assess the Efficacy, Safety, PK, and PD of Dasiglucagon When Administered as a Rescue Therapy for Severe Hypoglycemia in Pediatric Patients Below 6 Years of Age With Type 1 Diabetes (T1D)

NCT05378672·Phase 3
Completed

Primary endpoint: Change From Baseline in Plasma Glucose Concentration at 30 Minutes After IMP Injection

Interventionalopen8 enrolledStarted 2023-05Completion 2024-122 sites · United StatesZealand Pharma